FDA Inspection 1279451 — Varex Imaging Corporation

Varex Imaging Corporation — FEI 1717855

The FDA completed an inspection of Varex Imaging Corporation on Aug 25, 2025 in Salt Lake City, UT. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 6 citations were issued during this inspection. Product area: Devices.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Aug 25, 2025
Fiscal Year
2025
Product Type
Devices
Project Area
Compliance: Devices
Location
Salt Lake City, UT (United States)

Citations

IDCFRDescription
312021 CFR 820.80(a)Lack of or inadequate procedures - Acceptance activities
312121 CFR 820.80(b)Lack of or inadequate receiving acceptance procedures
313021 CFR 820.100(a)Lack of or inadequate procedures
326421 CFR 820.250(b)Sampling methods - Lack of or inadequate procedures
332821 CFR 820.180(b)Retention period
368021 CFR 820.70(a)Process control procedures, Lack of or inadequate procedures

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.